Sex-based mutational landscape confers sensitivity to checkpoint blockade immunotherapy in cutaneous melanoma
Jia, M.; Chi, T.
Show abstract
Anti-programmed cell death protein 1 (PD-1) therapy provided superior benefits in skin cutaneous melanoma (SKCM), but only a minority of patients responded. As SKCM had sex-based immunological differences, we sought to explore the potential interactions between sex and clinical responses to anti-PD-1 therapy in SKCM. We found that sex had significant effects on anti-PD-1 therapy. Tumor mutation burden (TMB) and neoantigen burden significantly correlated with the clinical responses to anti-PD-1 therapy only in males. Meanwhile, we recruited The Cancer Genome Atlas (TCGA) database to explore sex-based differences of the tumor microenvironment (TME) in SKCM. We observed that males with high TMB, especially in conjunction with interferon-gamma (IFN-{gamma}) signaling, significantly correlated with increased PD-L1 expression, major histocompatibility complex (MHC) class I gene expression, and the infiltration of cytotoxic T lymphocytes (CTLs). In addition, TMB and anti-PD-1 efficacy in SKCM each correlated with homologous recombination repair (HRR) gene BRCA2 mutations, but only in males. Taken together, these data revealed that in SKCM, high TMB correlated with prominent immunotherapeutic TME only in males, and that gender should be taken into account when predicting the efficacy of anti-PD-1 therapy for SKCM.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- MMP2 As An Independent Prognostic Stratifier In Oral Cavity Cancers 94%
- CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts 93%
- CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade 93%
Similar papers in this journal
- Conserved angio-immune subtypes of the cancer microenvironment predict response to immune checkpoint blockade therapy 93%
- Spatial transcriptomics analysis identifies a unique tumor-promoting function of the meningeal stroma in melanoma leptomeningeal disease 92%
- Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: the phase I/II first-in-human MATINS trial 91%
Similar papers in this journal
- Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma 94%
- Suppression of tumor/host intrinsic CMTM6 drives anti-tumor cytotoxicity in a PD-L1 independent manner 93%
- Combining an alarmin HMGN1 peptide with PD-L1 blockade facilitates stem-like CD8+ T cell expansion and results in robust antitumor effects 93%
Similar papers in this journal
- Bcl6 Preserves the Suppressive Function of Regulatory T Cells during Tumorigenesis 94%
- Profiling tumor immune microenvironment of non-small cell lung cancer using multiplex immunofluorescence 94%
- Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy 94%
Similar papers in this journal
- Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade 93%
- Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models 92%
- SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.